Related Experiment Video
Updated: Aug 16, 2025

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
miR194 hypomethylation regulates coronary artery disease pathogenesis
Lian Duan1, Yongmei Liu1, Jun Li1
1Department of Cardiology, Guang Anmen Hospital, No. 5 Beixiange, Xicheng District, Beijing, China.
Insights
This study reveals a novel DNA methylation-miRNA-mRNA network in coronary artery disease (CAD). The miR194-MAPK pathway is identified as a potential therapeutic target for CAD, offering new insights into disease mechanisms.
Area of Science:
- Cardiovascular Science
- Epigenetics
- Molecular Biology
Background:
- Coronary artery disease (CAD) is a prevalent condition with limited therapeutic options.
- Epigenetic dysregulation is increasingly recognized as a key factor in CAD pathogenesis.
Purpose of the Study:
- To elucidate a novel DNA methylation-miRNA-mRNA regulatory network in CAD.
- To identify key signaling pathways involved in CAD progression and potential therapeutic targets.
Main Methods:
- DNA methylation assays
- miRNA and mRNA sequencing
- Bioinformatics analyses
- Pyrosequencing, methylation PCR, and qRT-PCR for pathway validation.
Main Results:
- A unique DNA methylation-miRNA-mRNA regulatory network for CAD was identified.
- The miR194 promoter-miR194-MAPK signaling pathway was pinpointed as a crucial component.
- This pathway was implicated in CAD pathogenesis through apoptosis.
Conclusions:
- The identified network and miR194-MAPK pathway offer novel insights into CAD.
- The miR194-MAPK signaling pathway represents a potential therapeutic target for CAD.
- This research enhances the understanding of miRNA methylation, miRNA, and mRNA roles in CAD.
Abstract:
Coronary artery disease (CAD) is one of the most common heart diseases, characterized by the hardening and narrowing of arteries, resisting blood supply to cardiac muscle. Despite extensive research, the pathogenesis and therapeutic options for CAD remain limited. Epigenetic regulation plays a critical role in CAD progression. Here, we report a unique DNA methylation-miRNA-mRNA regulatory network for CAD, delineated through DNA methylation assays, miRNA and mRNA sequencing, bioinformatics analyses. We also identified key signaling pathways in this network, including the miR194 promoter-miR194-MAPK signaling pathway by pyrosequencing, methylation PCR, qRT-PCR. This pathway could play a role in CAD by apoptosis. Our findings suggested that this signaling pathway may be a potential therapeutic target for CAD. We believe that our study significantly contributes to an improved understanding of the role of specific miRNAs methylation, miRNA, and mRNAs in CAD pathogenesis.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Regulation of Angiogenesis and Blood Supply
Coronary Artery Disease IV: Preventive Measures
Epigenetic Regulation
X-chromosome...
MicroRNAs

